✦ LIBER ✦

Construction of Immunoradiometric Assay for Circulating c-erbB-2 Protooncogene Product in Advanced Breast Cancer Patients

✍ Scribed by Hosono, Makoto ;Saga, Tsuneo ;Sakahara, Harumi ;Kobayashi, Hisataka ;Shirato, Makoto ;Endo, Keigo ;Yamamoto, Tadashi ;Akiyama, Tetsu ;Toyoshima, Kumao ;Konishi, Junji

Book ID: 108579780
Publisher: Wiley (Blackwell Publishing)
Year: 1993
Tongue: English
Weight: 302 KB
Volume: 84
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1993.tb02848.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of immunohistochemical c-Er

Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer

✍ Syed Abdus Aziz; Shahid Pervez; Shaista Khan; Naila Kayani; Syed Igbal Azam; Moh 📂 Article 📅 2001 🏛 Springer Netherlands 🌐 English ⚖ 706 KB

Determination of a fragment of the c-erb

Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients

✍ B. Kynast; L. Binder; D. Marx; B. Zoll; H. -J. Schmoll; M. Oellerich; A. Schauer 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 414 KB

Influence of circulating c-erbB-2 serum

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

✍ Tanja Fehm; Peter Maimonis; Stephen Weitz; Yosh Teramoto; Alexander Katalinic; W 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 37 KB

287 Development and validation of a real

287 Development and validation of a real-time multiplex PCR assay for the simultaneous quantification of CK-19, MAGE-A3, HER-2 and PBGD in circulating tumor cells of breast cancer patients

✍ A. Strati; A. Markou; N. Malamos; V. Georgoulias; E.S. Lianidou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

In vivo manipulation of Vγ9Vδ2 T cells w

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

✍ S. Meraviglia; M. Eberl; D. Vermijlen; M. Todaro; S. Buccheri; G. Cicero; C. La 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

PCN9 VALIDITY OF PROPORTIONAL HAZARDS (P

PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+ (HER2+) METASTATIC BREAST CANCER (MBC) RECEIVING LAPATINIB PLUS CAPECITABINE (L+C) VERSUS CAPECITABINE ONLY (C-ONLY)

✍ O Sofrygin; T Delea; P Tappenden; J Karnon; MM Amonkar; M Walker 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB